ArticleWorld journal of gastrointestinal surgery2025
Clinical value of predicting bleeding after endoscopic submucosal dissection for early esophageal cancer.
Article in World journal of gastrointestinal surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Predicting post-ESD bleeding in elderly patients with early gastrointestinal cancer: an explainable model based on endoscopic features.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe incidence of esophageal cancer is high, and its prognosis is poor. Endoscopic submucosal dissection (ESD) is an important, minimally invasive treatment for early esophageal cancer, but the risk of postoperative bleeding affects its efficacy.
aimTo explore risk factors of bleeding after ESD and evaluate the predictive value of a gradient boosting machine (GBM) model for postoperative bleeding.
methodsThe clinical data of 178 early esophageal cancer patients who underwent ESD at the Affiliated Hospital of Xuzhou Medical University from October 2019 to October 2024 were analyzed retrospectively. Patients were divided into two groups (bleeding and non-bleeding). Univariate and multivariate logistic regression analyses identified risk factors for postoperative bleeding, leading to the construction of the GBM prediction model. The receiver operating characteristic (ROC) curve evaluated the predictive efficacy of the GBM model and bleeding after ESD trend from Japan (BEST-J) score.
resultsAmong 178 patients who received ESD treatment, 29 cases (16.29%) had bleeding, and 149 cases (83.71%) had no bleeding. The average BEST-J score and the proportion of high-risk and extremely high-risk patients were higher in the bleeding group than in the non-bleeding group (
conclusionThe GBM prediction model based on tumor size ≥ 3 cm, surgical bleeding, and high CRP levels is more effective than the BEST-J score at predicting bleeding after ESD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.